business
Elan considered buying Royalty before counter bid
Elan Corp considered buying New York investment firm Royalty Pharma last year, about six months before Royalty Pharma turned around with an acquisition proposal for Elan thatās now valued at about $5.7bn (ā¬4.33bn).













































